efgartigimod PH20 SC
ARGX-113-2009
Phase 3 mab completed
Quick answer
efgartigimod PH20 SC for Bullous Pemphigoid is a Phase 3 program (mab) at argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- argenx
- Indication
- Bullous Pemphigoid
- Phase
- Phase 3
- Modality
- mab
- Status
- completed